Home › Funds › 5AM Venture Management, LLC › TRDA

5AM Venture Management, LLC position in TRDA

ENTRADA THERAPEUTICS INC · Health Care

5AM Venture Management, LLC reported holding 4,056,379 shares of TRDA (ENTRADA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$29.9M, representing 10.37% of its reported portfolio and ranking #3 among its reported holdings. 5AM Venture Management, LLC has disclosed TRDA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.06M sh
Reported value held$29.85M
Portfolio Weight10.37%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How 5AM Venture Management, LLC's TRDA position evolved

5AM Venture Management, LLC first disclosed a stake in TRDA in Q3 2023 at 4,408,379 shares (US$69.7M). The position peaked in Q4 2024 at 4,408,379 shares, worth US$76.2M. Across 12 filings, 5AM Venture Management, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 4,056,379 shares valued at US$29.9M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.41M $69.65M New
Q4 2023 4.41M $66.52M Hold
Q1 2024 4.41M $62.47M Hold
Q2 2024 4.41M $62.82M Hold
Q3 2024 4.41M $70.45M Hold
Q4 2024 4.41M $76.22M Hold
Q1 2025 4.41M $39.85M Hold
Q2 2025 4.31M $28.95M Reduce
Q3 2025 4.26M $24.69M Reduce
Q4 2025 4.06M $41.70M Reduce
Q1 2026 4.06M $51.19M Hold
Q2 2026 4.06M $29.85M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRDA and 13F data

TRDA (ENTRADA THERAPEUTICS INC) is a Health Care company. 36 other funds we track also report a position in TRDA — the largest reported positions include BAKER BROS. ADVISORS LP (US$37.3M), Merck & Co., Inc. (US$12.8M), MPM BioImpact LLC (US$9.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRDA

All TRDA fund holders →

FAQ

How long has 5AM Venture Management, LLC held TRDA?

5AM Venture Management, LLC has disclosed TRDA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is 5AM Venture Management, LLC's current position in TRDA?

As of Q2 2026, 5AM Venture Management, LLC holds 4.06M shares of TRDA (ENTRADA THERAPEUTICS INC), valued at $29.85M, representing 10.37% of its reported portfolio and ranking #3.

Has 5AM Venture Management, LLC been buying or selling TRDA?

In the latest 13F filing (Q2 2026), 5AM Venture Management, LLC held unchanged its position in TRDA. The position peaked in Q4 2024 at 4.41M shares.

Which other funds hold TRDA?

Other major institutional holders of TRDA include BAKER BROS. ADVISORS LP, Merck & Co., Inc., MPM BioImpact LLC, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.